Related content

Strategies to Reduce Vascular Risk Associated with Obesity

By  

Current Vascular Pharmacology, Vol. 5, Iss. 4, 2007-01 ,pp. : 249-258

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to high-fat-diet-induced obesity and sexual dimorphism in the metabolic responses of transgenic mice with moderate uncoupling protein 3 overexpression in glycolytic skeletal muscles

By Tiraby C.   Tavernier G.   Capel F.   Mairal A.   Crampes F.   Rami J.   Pujol C.   Boutin J.   Langin D.  

Diabetologia, Vol. 50, Iss. 10, 2007-10 ,pp. : 2190-2199

Springer Publishing Company

Access to resources Recommend Favorite

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro³)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice

By Irwin N.   McClean P.   O’Harte F.   Gault V.   Harriott P.   Flatt P.  

Diabetologia, Vol. 50, Iss. 7, 2007-07 ,pp. : 1532-1540

Springer Publishing Company

Access to resources Recommend Favorite

Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases

By Matsuda Morihiro   Shimomura Iichiro  

Reviews in Endocrine and Metabolic Disorders, Vol. 15, Iss. 1, 2014-03 ,pp. : 1-10

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic complications of obesity

By Grundy Scott  

Endocrine Journal, Vol. 13, Iss. 2, 2000-10 ,pp. : 155-165

Humana Press, Inc

Access to resources Recommend Favorite